| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.03 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |